Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.15
+0.14 (2.00%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Kyntra Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 183.19 | 183.45 | -47.58 | -284.23 | -293.65 | -290.02 |
Depreciation & Amortization | 0.21 | 0.75 | 2.69 | 9.93 | 10.6 | 14.81 |
Loss (Gain) From Sale of Assets | -30.87 | - | 2.55 | 0 | -0 | 0.23 |
Asset Writedown & Restructuring Costs | - | 2.06 | - | 24.64 | - | 60 |
Loss (Gain) From Sale of Investments | -0.35 | -0.07 | -1.68 | -3.79 | 1.62 | 2.51 |
Loss (Gain) on Equity Investments | -1.38 | -2.49 | -3.97 | -2.64 | -1.57 | -1.01 |
Stock-Based Compensation | 3.99 | 6.58 | 25.22 | 50.77 | 65.6 | 71.16 |
Other Operating Activities | -42.02 | -42.02 | 2.23 | 9.99 | 1.04 | - |
Change in Accounts Receivable | 0.33 | -2.54 | -6.74 | 3.43 | 0.77 | 25.18 |
Change in Inventory | 1.51 | 5.36 | 22.28 | -1.7 | -11 | -14.16 |
Change in Accounts Payable | -2.2 | -27.65 | 14.51 | -15.51 | 5.91 | 0.81 |
Change in Unearned Revenue | -141.5 | -136.43 | -28.3 | -28.17 | -4.13 | 57.64 |
Change in Other Net Operating Assets | -8.96 | 8.23 | -119.22 | -77.75 | 78.89 | -9.38 |
Operating Cash Flow | -38.05 | -4.77 | -138 | -315.02 | -145.93 | -82.23 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -0.01 | -0.04 | -0.27 | -2.52 | -3.74 | -5.19 |
Sale of Property, Plant & Equipment | - | - | 1.05 | - | 0.01 | - |
Cash Acquisitions | - | - | - | 0.66 | - | - |
Divestitures | 100.55 | 96.62 | - | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | -35 | -25 |
Investment in Securities | -44.4 | -61.16 | 125.21 | 155.52 | 127.85 | -396.79 |
Investing Cash Flow | 56.14 | 35.42 | 125.99 | 153.66 | 89.12 | -426.97 |
Long-Term Debt Issued | - | - | - | 74.08 | - | - |
Long-Term Debt Repaid | - | -80.56 | -0.04 | -0.48 | -0.54 | -5.89 |
Net Debt Issued (Repaid) | -80.56 | -80.56 | -0.04 | 73.59 | -0.54 | -5.89 |
Issuance of Common Stock | - | - | 0.14 | 52.14 | 4.18 | 12.7 |
Repurchase of Common Stock | -0.03 | -0.07 | -0.35 | -0.24 | -5.17 | -7.37 |
Other Financing Activities | -5.35 | -5.4 | - | -2.75 | 48.3 | - |
Financing Cash Flow | -85.94 | -86.03 | -0.26 | 122.75 | 46.78 | -0.56 |
Foreign Exchange Rate Adjustments | -1.34 | 1.08 | 0.75 | -3.4 | -5.48 | 2.6 |
Net Cash Flow | -69.2 | -54.31 | -11.51 | -42.01 | -15.52 | -507.17 |
Free Cash Flow | -38.06 | -4.81 | -138.27 | -317.54 | -149.67 | -87.42 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -824.57% | -74.72% | -466.78% | -678.46% | -106.35% | -37.15% |
Free Cash Flow Per Share | -9.40 | -1.19 | -34.55 | -81.58 | -39.98 | -23.66 |
Levered Free Cash Flow | 54.07 | 5.11 | -150.77 | -273.99 | -104.83 | -98.14 |
Unlevered Free Cash Flow | 59.88 | 10.58 | -145.61 | -268.94 | -103.93 | -97.47 |
Cash Interest Paid | 7.83 | 7.83 | 16.21 | 6.38 | 0.1 | 0.09 |
Change in Working Capital | -150.82 | -153.03 | -117.46 | -119.69 | 70.43 | 60.08 |